Torrent Pharmaceuticals Ltd. — M&A Activity 2023

May 18, 2023

==> picture [95 x 30] intentionally omitted <==

18[th] May, 2023

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1[st] Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)

Mumbai – 400 051 (NSE Scrip Code: TORNTPHARM)

Dear Sir,

Sub.: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

We would like to inform that Hon'ble National Company Law Tribunal, Ahmedabad Bench ("NCLT"), vide its Order dated 17[th] May, 2023, has sanctioned the Scheme of Arrangement in the nature of Amalgamation between Curatio Health Care (I) Private Limited, a wholly owned subsidiary of the Company with Torrent Pharmaceuticals Limited and their respective shareholders and creditors ("Scheme") pursuant to the provisions of Section 230 to 232 and other applicable provisions of the Companies Act, 2013 and rules made thereunder. A copy of the said Order is available on the website of the Company.

The above is in continuation to our earlier communication dated 21-Dec-22 intimating the approval of the said Scheme of Amalgamation by the Board of Directors of the Company in its meeting held on 21-Dec-22.

The Scheme will become effective upon filing of the said Order with the Registrar of Companies, Gujarat.

Kindly take note of the above.

Thanking you,

Yours sincerely,

For TORRENT PHARMACEUTICALS LIMITED

CHINTAN Digitally signed by CHINTAN MAHESHKUMAR MAHESHKUMAR TRIVEDI Date: 2023.05.18 19:30:12 TRIVEDI +05'30'

CHINTAN M. TRIVEDI COMPANY SECRETARY

___________________________________________________________________________________

TORRENT PHARMACEUTICALS LIMITED

CIN: L24230GJ1972PLC002126

Reg.Office : Torrent House, Off Ashram Road, Ahmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com, Email : InvestorServices@TorrentPharma.com